Tudor Investment Corp
KITE

Tudor Investment Corp’s Kite Pharma, Inc. KITE Stock Holding History

Tudor Investment Corp’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,055
Closed -$524K – 1358
2017
Q2 		$524K Buy
+5,055
New +$412K 0.02% 556
2016
Q4 		– Sell
-6,388
Closed -$357K – 1753
2016
Q3 		$357K Buy
+6,388
New +$356K 0.01% 923
2015
Q2 		– Sell
-3,767
Closed -$217K – 1781
2015
Q1 		$217K Buy
+3,767
New +$252K 0.01% 1253

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Tudor Investment Corp's KITE Position: Q3 2017 in Review

Tudor Investment Corp sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 5,055 shares — an estimated $524K sold.

Tudor Investment Corp first reported a position in KITE in Q1 2015 and held it in 3 quarters. The position peaked at $524K in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Tudor Investment Corp reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Tudor Investment Corp sold 5,055 Kite Pharma, Inc. shares in Q3 2017, an estimated $524K.
  • Tudor Investment Corp first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 3 quarters.
  • Tudor Investment Corp's Kite Pharma, Inc. position peaked at $524K in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.